Cite
HARVARD Citation
Geven, C. et al. (2018). Effects of the Humanized Anti-Adrenomedullin Antibody Adrecizumab (HAM8101) on Vascular Barrier Function and Survival in Rodent Models of Systemic Inflammation and Sepsis. Shock. 50 (6), p. . [Online].